Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
₹ 13.4
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Very low or no dividends
Data is available to registered users only
Data is available to registered users only
About
Norris Medicines Ltd. engages in the manufacture of pharmaceuticals, medicinal chemical, and botanical products. Its products range include antibiotic range, anti inflammatory, anti emetic, nutrition, cough and cold, skin and allergy, anti malarial, diabetic, and cardiac. The company was founded in 1990 and is headquartered in Ankleshwar, India.
Company Valuation
From both historical and forecast perspectives, the stock is moderately underpriced compared to similar stocks.
Data is available to registered users only
Buy
Sell